Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 212597
Company: AUROBINDO PHARMA
Company: AUROBINDO PHARMA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/20/2026 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
PIRFENIDONE
CAPSULE;ORAL; 267MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ESBRIET | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | Yes | AB | 022535 | LEGACY PHARMA |
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | No | AB | 212731 | ACCORD HLTHCARE |
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | No | AB | 212569 | AMNEAL |
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | No | AB | 212597 | AUROBINDO PHARMA |
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | No | AB | 212724 | LAURUS |
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | No | AB | 212748 | MACLEODS PHARMS LTD |
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | No | AB | 212600 | SANDOZ |
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL | Prescription | No | AB | 212077 | SCIEGEN PHARMS |